Zealand Pharma AS (ZEAL) Stock Balance Sheet
NASDAQ:ZEAL - Nasdaq - US98920Y3045 - ADR - Currency: USD
| MRQ (2022-6-30) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 553.24M | 1.13B | 960.22M | 1.08B | 860.63M | |||
| Marketable Securities | 311.20M | 299.04M | 297.35M | 299.45M | 298.61M | |||
| Receivables | 82.72M | 110.39M | 61.93M | 15.79M | 7.84M | |||
| Inventories | 818.00K | 118.44M | 65.04M | N/A | N/A | |||
| Other Current Assets | 52.74M | 64.63M | 35.16M | 30.75M | 11.74M | |||
| Total Current Assets | 1.00B | 1.72B | 1.42B | 1.43B | 1.18B | |||
| Non-Current Assets | ||||||||
| PPE Net | 185.78M | 221.45M | 213.04M | 125.34M | 15.63M | |||
| Investments And Advances | 38.56M | 26.91M | 32.33M | 35.63M | 32.58M | |||
| Intangibles | 2.53M | 53.79M | 57.48M | 2.48M | N/A | |||
| Other Non-Current Assets | 26.20M | 42.62M | 38.14M | 9.01M | 2.76M | |||
| Total Non-Current Assets | 255.83M | 346.03M | 342.26M | 172.46M | 50.97M | |||
| TOTAL ASSETS | 1.26B | 2.07B | 1.76B | 1.60B | 1.23B | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 13.83M | 14.90M | 14.07M | 7.69M | 0.00 | |||
| Accrued Expenses | N/A | 84.80M | 101.03M | 36.08M | 34.97M | |||
| Accounts Payable | 34.83M | 64.56M | 70.38M | 57.53M | 32.65M | |||
| Other Current Liabilities | 212.92M | 170.06M | 169.78M | 93.83M | 45.89M | |||
| Total Current Liabilities | 261.58M | 334.32M | 355.26M | 195.13M | 113.52M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 471.60M | 772.53M | 116.05M | 78.07M | 0.00 | |||
| Other Non-Current Liabilities | 18.43M | 32.98M | 61.33M | 83.64M | N/A | |||
| Total Non-Current Liabilities | 490.02M | 805.51M | 177.38M | 161.71M | 0.00 | |||
| TOTAL LIABILITIES | 751.61M | 1.14B | 532.64M | 356.84M | 113.52M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | 439.38M | -3.31B | -2.29B | -1.44B | -894.00M | |||
| Additional Paid In Capital | N/A | 4.25B | 3.47B | 2.65B | 1.98B | |||
| Common Shares | 46.53M | 43.63M | 39.80M | 36.05M | 30.79M | |||
| Treasury Stock | N/A | -71.89M | N/A | N/A | N/A | |||
| Other Shareholders' Equity | 19.04M | 14.15M | 8.98M | N/A | N/A | |||
| Shares Outstanding | 48.24M | 45.05M | 41.42M | 37.52M | 32.03M | |||
| Tangible Book Value per Share | 10.86 | 20.22 | 29.49 | 34.46 | 36.33 | |||
| Total Shareholders' Equity | 504.95M | 927.80M | 1.23B | 1.24B | 1.12B | |||
| TOTAL LIABILITIES AND EQUITY | 1.26B | 2.07B | 1.76B | 1.60B | 1.23B | |||
| Statistics | ||||||||
| Debt/Equity | 0.93 | 0.83 | 0.09 | 0.06 | N/A | |||
| Current Ratio | 3.83 | 5.15 | 4.00 | 7.31 | 10.38 | |||
| Return On Assets (ROA) | -94.74% | -49.24% | -48.06% | -35.73% | 47.27% | |||
| Return On Equity (ROE) | -235.77% | -109.74% | -68.88% | -45.99% | 52.07% | |||
All data in DKK , ROIC based on taxRate of 0.21